Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance.
脂肪組織:胰高血糖素軸的新目標?與肥胖相關的胰島素抗性中的範式轉變。
Int J Mol Sci 2024-08-29
Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity.
褐色脂肪組織:糖肽樣肽1受體激動劑在肥胖治療中的新潛在靶點。
Int J Mol Sci 2023-05-31
Adipocentric origin of the common cardiometabolic complications of obesity in the young up to the very old: pathophysiology and new therapeutic opportunities.
肥胖常見的心臟代謝併發症在年輕至老年人中的脂肪細胞中心起源:病理生理學和新的治療機會。
Front Med (Lausanne) 2024-04-26
Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity.
肥胖症治療的研究性和新興胃抑制性胰高血糖素多肽(GIP)受體相關療法。
Expert Opin Investig Drugs 2024-07-10
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists.
GLP-1 及雙重 GIP/GLP-1 受體激動劑的作用機制與治療應用。
Front Endocrinol (Lausanne) 2024-08-08